Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/6207
Title: Novo radiofármaco ajudará no diagnóstico de tumores neuroendócrinos por PET-CT
Other Titles: Informe INCA 415
Authors: Instituto Nacional de Câncer José Alencar Gomes da Silva
Instituto Nacional de Câncer (Brasil)
INCA
Keywords: Compostos Radiofarmacêuticos
Radiopharmaceuticals
Radiofármacos
Tumores Neuroendócrinos/diagnóstico
Neuroendocrine Tumors/diagnosis
Tumores Neuroendocrinos/diagnóstico
Pujatt, Priscilla Brunelli
Issue Date: Jan-2022
Publisher: INCA
URI: http://sr-vmlxaph03:8080/jspui/handle/123456789/6207
Appears in Collections:Informe INCA 415

Files in This Item:
File Description SizeFormat 
Informe-INCA-2022-415-4-Novo-radiofarmaco-ajudara.pdf212.84 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.